About

Oxehealth is a global leader in vision-based patient monitoring and management, helping clinicians to deliver safer, higher-quality, and more efficient care.

Our Oxevision system is the result of a decade-long research programme in collaboration with patients, NHS nurses and doctors, and it supports clinicians by complementing patient care with 24/7 safety data.

The technology includes a contact-free infrared-sensitive camera that works with cleared medical device software to deliver vital signs and activity insights to clinicians. This enables staff to plan patient care and intervene proactively to help patients in inpatient mental health settings.

The Vital Signs software is a Class IIa cleared medical device in the UK & Europe and a Class II medical device in the US. It enables clinicians to measure patients’ cardio-respiratory vital signs without a device being attached, helping to promote patient independence and preserve their privacy and dignity.

Oxevision’s Activity Tracker software (a Class I cleared medical device in the UK and Europe) can notify clinicians of activity that may indicate a patient needs help, for example, if someone is at risk of falls is getting out of bed.

Oxehealth’s ongoing research continues the development of novel technology to transform mental health diagnosis and care.

Key Facts

Research with our partners, who use Oxevision as part of their clinical practice, has found: 71% reduction in enhanced observations (Older Adult ward)1 68% reduction in A&E visits (Older Adult ward)1 48% reduction in night-time falls (Older Adult ward)1 26% reduction in assaults (PICU ward)2 In addition to this, Oxevision has also helped:3 85% of staff to feel they can better manage patient risk 73% of staff to feel they can better manage their own safety 81% of patients to feel an improved sense of safety 71% of patients to feel they sleep better Oxehealth has won the Health Service Journal (HSJ) Patient Safety Award for the Best Healthtech Solution as well as several HSJ Partnership Awards and the Regional Parliamentary The Future NHS Award. Oxevision has also been highlighted as an example of outstanding practice by the UK regulatory body, the Care Quality Commission (CQC).4 1 Wright, K., & Singh, S. (2022). Reducing falls in dementia inpatients using vision-based technology. Journal of Patient Safety, 18(3), 177-181. 2 Ndebele, F., Gibson, O., Bayley, D., Wood, C., & Wright, K. (2022). Non-contact health monitoring to support care in a psychiatric intensive care unit. Journal of Psychiatric Intensive Care. Manuscript accepted for publication. 3 Data compiled from six NHS trusts. Percentages refer to the proportion of respondents who agreed or strongly agreed with the statement. Sample size (N) from first to last item in list: 215, 211, 78, 76. 4 See https://oxe.health/cqc-cwpt (p. 11).

Successes in UK/NHS

Oxehealth is now contracted with c. 50% of England’s NHS Mental Health Trusts.

Company details

Solutions

Delivering advanced patient care

Specialism

Acute and emergency care monitoring

Company details

Want to connect with this innovator?

Make an enquiry

Markets already exporting to

UK, Sweden, US

Desired Markets

Japan, Australia, Canada

Desired customer types

Inpatient mental/behavioural health providers (public and private)

Want to connect with this innovator?
Make an enquiry
Close
This field is required
This field is required
This field is required
This field is required
This field is required

Thank you

We are processing your request and will return your contact as soon as possible.